KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Gains from Investment Securities (2017 - 2026)

Elanco Animal Health's Gains from Investment Securities history spans 9 years, with the latest figure at -$214.0 million for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities fell 1628.57% to -$214.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $12.0 million, a 14.29% decrease, with the full-year FY2025 number at $12.0 million, down 14.29% from a year prior.
  • Gains from Investment Securities hit -$214.0 million in Q4 2025 for Elanco Animal Health, down from $225.0 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for ELAN hit a ceiling of $225.0 million in Q3 2025 and a floor of -$214.0 million in Q4 2025.
  • Historically, Gains from Investment Securities has averaged $1.8 million across 5 years, with a median of $2.0 million in 2021.
  • The widest YoY moves for Gains from Investment Securities: up 5725.0% in 2025, down 1628.57% in 2025.
  • Tracing ELAN's Gains from Investment Securities over 5 years: stood at -$9.0 million in 2021, then surged by 211.11% to $10.0 million in 2022, then decreased by 20.0% to $8.0 million in 2023, then soared by 75.0% to $14.0 million in 2024, then tumbled by 1628.57% to -$214.0 million in 2025.
  • Business Quant data shows Gains from Investment Securities for ELAN at -$214.0 million in Q4 2025, $225.0 million in Q3 2025, and -$1.0 million in Q2 2025.